Holen Sie sich die Stockscreener-App
59.75
0.10%
0.06
Handel nachbörslich:
59.81
0.06
+0.10%
Schlusskurs vom Vortag:
$59.69
Offen:
$59.68
24-Stunden-Volumen:
451.63K
Relative Volume:
0.28
Marktkapitalisierung:
$2.33B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-54.42M
KGV:
-23.42
EPS:
-2.5513
Netto-Cashflow:
$-50.87M
1W Leistung:
-0.03%
1M Leistung:
+0.91%
6M Leistung:
+188.79%
1J Leistung:
+1,280%
1-Tages-Spanne:
$59.68
$59.81
1-Wochen-Bereich:
$59.47
$59.87
52-Wochen-Spanne:
$3.60
$59.95
Longboard Pharmaceuticals Inc Stock (LBPH) Company Profile
Firmenname
Longboard Pharmaceuticals Inc
Sektor
Branche
Telefon
619-592-9775
Adresse
4275 EXECUTIVE SQUARE, LA JOLLA
Vergleichen Sie LBPH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| LBPH | 59.75 | 2.33B | 0 | -54.42M | -50.87M | -2.5513 |
| VRTX | 467.01 | 119.87B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 762.00 | 83.27B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 567.90 | 33.96B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 232.27 | 30.18B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 101.87 | 24.42B | 3.30B | -501.07M | 1.03B | 11.54 |
Longboard Pharmaceuticals Inc Stock (LBPH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-10-24 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2023-04-27 | Eingeleitet | B. Riley Securities | Buy |
| 2021-04-07 | Eingeleitet | Evercore ISI | Outperform |
| 2021-04-06 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-04-06 | Eingeleitet | Citigroup | Buy |
| 2021-04-06 | Eingeleitet | Guggenheim | Buy |
Alle ansehen
Longboard Pharmaceuticals Inc Aktie (LBPH) Neueste Nachrichten
Braun Stacey Associates Inc. Takes Position in Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) - MarketBeat
LBPHLongboard Pharmaceuticals, Inc. Latest Stock News & Market Updates - StockTitan
Longboard Pharmaceuticals Initiates Phase 3 DEEp Ocean Study Evaluating Bexicaserin in Developmental and Epileptic Encephalopathies - Marketscreener.com
Longboard Pharmaceuticals Advances Neurological Treatments - TipRanks
Longboard Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Corporate Updates - BioSpace
Longboard Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Longboard Pharma Reports Strong Q3, Advances Phase 3 Trial Amid Lundbeck Acquisition Deal | LBPH Stock News - StockTitan
FMR LLC Reduces Stake in Longboard Pharmaceuticals Inc - GuruFocus.com
How the (LBPH) price action is used to our Advantage - Stock Traders Daily
Vanguard Group Inc's Strategic Acquisition in Longboard Pharmace - GuruFocus.com
Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) Position Increased by Emerald Advisers LLC - MarketBeat
Longboard Pharmaceuticals (NASDAQ:LBPH) Hits New 1-Year High – Here’s What Happened - Defense World
Longboard Pharmaceuticals stock soars to all-time high of $59.95 By Investing.com - Investing.com South Africa
Longboard Pharmaceuticals (NASDAQ:LBPH) Reaches New 52-Week HighShould You Buy? - MarketBeat
500: Something went wrong - Investing.com
Longboard Pharmaceuticals Inc options imply 0.8% move in share price post-earnings - TipRanks
LONGBOARD PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Longboard Pharmaceuticals, Inc.LBPH - Business Wire
Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) Given Consensus Rating of "Hold" by Analysts - MarketBeat
Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) Given Consensus Rating of “Hold” by Analysts - Defense World
Lundbeck to Buy Longboard Pharma in $2.6 Billion Deal - MSN
(LBPH) Trading Signals - Stock Traders Daily
B. Riley Offloads Great American To Oaktree To Cut Debt - Finimize
Longboard Pharmaceuticals stock soars to all-time high of $59.48 By Investing.com - Investing.com Australia
Longboard Pharmaceuticals (NASDAQ:LBPH) Hits New 1-Year HighStill a Buy? - MarketBeat
Longboard Pharmaceuticals stock soars to all-time high of $59.48 - Investing.com India
$DRUG 5,900% Weekly Surge Turns Attention. Cybin ($CYBN) Rallying 23% This Week In Anticipation For Major Milestones - FinanceFeeds
Longboard Pharmaceuticals (NASDAQ:LBPH) Sees Unusually-High Trading VolumeShould You Buy? - MarketBeat
Oklo, CleanSpark And Wolfspeed Are Among Top 7 Mid Cap Gainers Last Week (Oct 14-18): Are The Others In Your Portfolio? - Benzinga
The week in pharma: action, reaction and insight – week to October 19 | Pharmaceutical | The Pharmaletter - The Pharma Letter
Longboard Pharmaceuticals’ stock soars amid Lundbeck’s $2.6 billion deal to acquire the company - MSN
Longboard Pharmaceuticals Stock Soars 51%. It’s Being Bought for $2.6 Billion. - MSN
Longboard soars as Lundbeck to buy company for equity value of $2.6B - MSN
Longboard Pharmaceuticals Strikes $2.6 Billion Deal to Be Acquired by Lundbeck - MSN
SG Americas Securities LLC Buys Shares of 10,514 Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) - MarketBeat
Dow Surges Over 200 Points; Longboard Pharmaceuticals Shares Jump - MSN
Taxation With Representation: Baker, Simpson, Ropes - Law360
Pα+ Psychedelic Bulletin #177: Bright Minds Surges on Longboard’s Seizure Drug Success; Kasvu Therapeutics Is Developing Psychoplastogens With a TrkB Twist - Psychedelic Alpha
HC Wainwright Reiterates Neutral Rating for Longboard Pharmaceuticals (NASDAQ:LBPH) - Defense World
Longboard Pharmaceuticals CMO sells $983,936 in stock By Investing.com - Investing.com South Africa
Randall Kaye Sells 16,667 Shares of Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) Stock - MarketBeat
STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Investigates the Merger of Longboard Pharmaceuticals, Inc.LBPH - The Malaysian Reserve
Longboard Pharmaceuticals (NASDAQ:LBPH) Lowered to Hold at Wedbush - MarketBeat
Longboard Set to be Acquired by Lundbeck for $2.6B, Stock Soars 52% - MSN
Lundbeck's billion-dollar acquisition will cost layoffs - MedWatch
Lundbeck to Acquire Longboard Pharmaceuticals - CHEManager
Lundbeck’s $2.6 Billion Acquisition of Longboard Pharmaceuticals - Global Legal Chronicle
Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) Short Interest Update - MarketBeat
Lundbeck picks up Longboard Pharmaceuticals for $2.6B - MM+M Online
Longboard Pharmaceuticals downgraded to Neutral from Buy at B. Riley - TipRanks
Finanzdaten der Longboard Pharmaceuticals Inc-Aktie (LBPH)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.66%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):